These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6203847)

  • 1. Inhibition of tumour-induced angiogenesis by systemically administered protamine sulphate.
    Majewski S; Kamiński MJ; Szmurło A; Kamińska G; Malejczyk J
    Int J Cancer; 1984 Jun; 33(6):831-3. PubMed ID: 6203847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis.
    Robertson NE; Discafani CM; Downs EC; Hailey JA; Sarre O; Runkle RL; Popper TL; Plunkett ML
    Cancer Res; 1991 Feb; 51(4):1339-44. PubMed ID: 1705173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.
    Le Gonidec S; Chaves-Almagro C; Bai Y; Kang HJ; Smith A; Wanecq E; Huang XP; Prats H; Knibiehler B; Roth BL; Barak LS; Caron MG; Valet P; Audigier Y; Masri B
    FASEB J; 2017 Jun; 31(6):2507-2519. PubMed ID: 28242772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of carcinomatosis and bloody malignant ascites in the rat by an inhibitor of angiogenesis.
    Heuser LS; Taylor SH; Folkman J
    J Surg Res; 1984 Mar; 36(3):244-50. PubMed ID: 6199588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of heparin in angiogenesis.
    Folkman J; Taylor S; Spillberg C
    Ciba Found Symp; 1983; 100():132-49. PubMed ID: 6197257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protamine is an inhibitor of angiogenesis.
    Taylor S; Folkman J
    Nature; 1982 May; 297(5864):307-12. PubMed ID: 6176876
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
    Rofstad EK; Danielsen T
    Br J Cancer; 1998 Mar; 77(6):897-902. PubMed ID: 9528831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protamine sulfate inhibition of serum-induced mitogenic responses: differential effects on normal and neoplastic cells.
    Leibovich SJ; Polverini PJ
    J Natl Cancer Inst; 1984 Dec; 73(6):1337-47. PubMed ID: 6210390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of a DNA vaccine encoding an anchored-glycosylphosphatidylinositol tegumental antigen complexed to protamine sulphate on immunoprotection against murine schistosomiasis.
    Nascimento EJ; Amorim RV; Cavalcanti A; Alves VF; Nakazawa M; Pereira VR; Lucena-Silva N
    Mem Inst Oswaldo Cruz; 2007 Feb; 102(1):21-7. PubMed ID: 17293994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of protamine on human prostate carcinoma PC-3m using contrast enhanced Doppler ultrasound.
    Tang J; Li S; Li J; Zhang Y; Li X; Dong B; Shi H; Zhang G
    J Urol; 2003 Aug; 170(2 Pt 1):611-4. PubMed ID: 12853841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice.
    Lee KE; Iwamura M; Cockett AT
    Cancer Chemother Pharmacol; 1990; 26(6):461-3. PubMed ID: 1699679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine versus angiogenesis.
    Lancet; 1982 Jun; 1(8284):1283-4. PubMed ID: 6176824
    [No Abstract]   [Full Text] [Related]  

  • 15. Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis.
    Majewski S; Marczak M; Mlynarczyk B; Benninghoff B; Jablonska S
    Int J Dermatol; 2005 Jan; 44(1):14-9. PubMed ID: 15663652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protamine enhances uptake of cationic liposomes in angiogenic microvessels.
    Eichhorn ME; Strieth S; Krasnici S; Sauer B; Teifel M; Michaelis U; Naujoks K; Dellian M
    Angiogenesis; 2004; 7(2):133-41. PubMed ID: 15516834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of actions inhibiting neovascularization of the metastasis of Lewis lung carcinoma].
    Sopotsinskaia EB; Lisniak IA; Balitskiĭ KP
    Eksp Onkol; 1985; 7(5):68-71. PubMed ID: 2415319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
    Alam F; Al-Hilal TA; Chung SW; Park J; Mahmud F; Seo D; Kim HS; Lee DS; Byun Y
    J Control Release; 2015 Jan; 197():180-9. PubMed ID: 25445701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine sulphate inhibits pentasaccharide (SR80027)-induced bleeding without affecting its antithrombotic and anti-factor Xa activity in the rat.
    Bernat A; Herbert JM
    Haemostasis; 1996; 26(4):195-202. PubMed ID: 8872130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effect of heparin, chondroitin, dextran and protamine on the virulence of pseudorabies virus (Suid herpesvirus 1).
    Ramos-Kuri M; Kretschmer RR; Espinosa-Larios EL; Aguilar-Setién A
    Arch Invest Med (Mex); 1990; 21(1):29-33. PubMed ID: 2171447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.